Danziger Asaf 5
5 · NovoCure Ltd · Filed Jan 8, 2026
Insider Transaction Report
Form 5
NovoCure LtdNVCR
Danziger Asaf
Director
Transactions
- Award
Ordinary Shares
2025-12-31$10.99/sh+1$11→ 416,474 total
Footnotes (2)
- [F1]The reporting person is reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2025.